Please Wait
Applying Filters...
menu
    • menu
    Mix Gif-PSE
    News
    Viridian Eye Disease Drug Surpasses Expectations in late-stage

    06 May 2026

    // REUTERS

    BioNTech Closes Multiple Manufacturing Plants, Affecting 1,860

    06 May 2026

    // BIOSPACE

    Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial

    06 May 2026

    // FIERCE PHARMA

    DATA COMPILATION
    #PharmaFlow

    Amsa

    Contact Supplier

    Website

    Arvo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cep-q1-2026-update-cep-2-0-edqm-s-new-guidelines-strengthen-ecosystem-indian-firms-top-list-of-ceps-issued
    Menu

    Amsa

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2AMSA (Anonima Materie Sintetiche & Affini) S.p.A.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    arrow
    Arvo
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-02-20

    Amsa

    City : Como

    State :

    Country/Area : Italy

    Zip :

    District : ORA

    Center : CVM

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : No Action Indicated

    Inspection End Date : 2015-02-20

    Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    arrow
    Arvo
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2013-03-22

    Amsa

    City : Como

    State :

    Country/Area : Italy

    Zip :

    District : ORA

    Center : CVM

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : No Action Indicated

    Inspection End Date : 2013-03-22

    Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Amsa and get a quotation

    Amsa is a supplier offers 22 products (APIs, Excipients or Intermediates).

    Find Flecainide bulk with DMF, CEP, JDMF offered by Amsa

    Find Meloxicam bulk with DMF, CEP, JDMF offered by Amsa

    Find Metoclopramide Hydrochloride bulk with CEP, JDMF offered by Amsa

    Find Amantadine Hydrochloride bulk with DMF offered by Amsa

    Find Etodolac bulk with DMF offered by Amsa

    Find Glipizide bulk with DMF offered by Amsa

    Find Glycopyrronium Bromide bulk with DMF offered by Amsa

    Find Levodropropizine bulk with CEP offered by Amsa

    Find Lurasidone Hydrochloride bulk with DMF offered by Amsa

    Find Memantine Hydrochloride bulk with DMF offered by Amsa

    Find Metoclopramide bulk with JDMF offered by Amsa

    Find Bromhexine Hydrochloride bulk offered by Amsa

    Find Cysteamine Bitartrate bulk offered by Amsa

    Find Cysteamine Hydrochloride bulk offered by Amsa

    Find Diclofenac Epolamine bulk offered by Amsa

    Find Etodolac bulk offered by Amsa

    Find Glipizide bulk offered by Amsa

    Find Glycopyrronium Bromide bulk offered by Amsa

    Find Imepitoin bulk offered by Amsa

    Find Meloxicam bulk offered by Amsa

    Find Oxantel Pamoate bulk offered by Amsa

    Find Viloxazine Hydrochloride bulk offered by Amsa

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.